What Does Boston Scientific’s Debt Look Like?
Over the past three months, shares of Boston Scientific (NYSE:BSX) increased by 0.05%. Before we understand the importance of debt, let us look at how much debt Boston Scientific has.
10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Truist Securities Maintains Buy on Boston Scientific, Raises Price Target to $53
Truist Securities maintains Boston Scientific (NYSE:BSX) with a Buy and raises the price target from $52 to $53.
What Does Boston Scientific’s Debt Look Like?
Shares of Boston Scientific (NYSE:BSX) decreased by 6.16% in the past three months. Before having a look at the importance of debt, let us look at how much debt Boston Scientific has.
RBC Capital Initiates Coverage On Boston Scientific with Outperform Rating, Announces Price Target of $51
RBC Capital analyst Shagun Singh initiates coverage on Boston Scientific (NYSE:BSX) with a Outperform rating and announces Price Target of $51.
Ominous Death Cross Forms On Boston Scientific’s Chart
If history is any guide, there may be trouble ahead for shares of Boston Scientific (NYSE:BSX). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.
Boston Scientific To Participate In 2 Upcoming Investor Conferences: Nov. 15, 2021 At 8 a.m. EST For Stifel Healthcare Conference, Dec. 1, 2021 At 8 a.m. EST For Evercore ISI HealthCONx Conference
Boston Scientific Corporation (NYSE:BSX) will participate in two upcoming investor conferences.
On November 15, 2021, Dan Brennan, executive vice president and chief financial officer, and Lauren Tengler, vice
Boston Scientific Q3 Earnings Comes Inline With Wall Street Expectations
Boston Scientific Corporation (NYSE:BSX) generated net sales of $2.93 billion in Q3 of 2021, almost in line with the Wall…
Boston Scientific Q3 Adj. EPS $0.41 Beats $0.40 Estimate, Sales $2.93B Miss $2.97B Estimate
Boston Scientific (NYSE:BSX) reported quarterly earnings of $0.41 per share which beat the analyst consensus estimate of $0.40 by 2.5 percent. This is a 10.81 percent increase over earnings of $0.37 per share from the